CA Patent

CA2718939A1 — Novel solid forms of bendamustine hydrochloride

Assigned to Cephalon LLC · Expires 2009-10-01 · 17y expired

What this patent protects

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.

USPTO Abstract

Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.

Drugs covered by this patent

Patent Metadata

Patent number
CA2718939A1
Jurisdiction
CA
Classification
—
Expires
2009-10-01
Drug substance claim
No
Drug product claim
No
Assignee
Cephalon LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.